Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
Clinical trial NCT05644509 · UNKNOWN
Trial details
- NCT number
- NCT05644509
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.